Anti-CD28 x Anti-CD40 Bispecific Antibody (IgG-IgG) is designed to be expressed as three chains derived from the anti-CD28 and anti-CD40 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can increase T-cell proliferation, induce DC maturation and prime efficacy of cytotoxic T cells. It is designed for the research of Acute myeloid leukaemic (AML) therapy.
There are currently no customer reviews or questions for Anti-CD28 x Anti-CD40 Bispecific Antibody (IgG-IgG) (BSIG-056). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS